Filtered By:
Management: Marketing
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 200 results found since Jan 2013.
ReNeuron Provides Business Update and Results Notification
Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete
LONDON, May 8, 2019 -- (Healthcare Sales & Marketing Network) -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end... Regenerative Medicine, Ophthalmology, Neurology ReNeuron Group, retinitis pigmentosa, stroke, stem cell
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
ENGLEWOOD, Colo., July 22, 2019 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabili... Devices, Personnel Zynex, NeuroMove
Source: HSMN NewsFeed - July 22, 2019 Category: Pharmaceuticals Source Type: news
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
AUSTIN, Texas, Aug. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Harmonic Bionics, Inc. announced today that Christopher Prentice has been appointed Chief Executive Officer and member of the Harmonic Bionics Board of Directors effective immediate... Devices, Personnel Harmonic Bionics, stroke, spinal cord injury, neurorehabilitation
Source: HSMN NewsFeed - August 28, 2019 Category: Pharmaceuticals Source Type: news
How the Vaping Industry Is Using a Defensive Tactic Pioneered Decades Ago by Big Tobacco
Each week brings a new story of some calamity brought by vaping.
In late July, a Connecticut man filed suit against e-cigarette giant Juul Labs after suffering a massive stroke. The suit alleges that he became addicted while he was still a high schooler, even though the company says it is specifically taking action to prevent young people from trying the product. In August, an Illinois patient died after vaping, succumbing to a mysterious respiratory illness; news broke teens in the Midwest hospitalized with severe and unexplained respiratory symptoms; and the FDA announced that that it was investigating the relationship b...
Source: TIME: Health - October 2, 2019 Category: Consumer Health News Authors: Sarah Milov Tags: Uncategorized health Opinion politics Source Type: news
FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Sky Medical Technology furthers presence in 3.5bn1 dollar US market for VTE prevention
DARESBURY, England, Oct. 10, 2019 -- (Healthcare Sales & Marketing Network) -- UK-based medical devices company, Sky Medical Technology Ltd, has received U.S. Food a... Devices, FDA Sky Medical Technology, geko, Deep Vein Thrombosis, venous thromboembolism
Source: HSMN NewsFeed - October 10, 2019 Category: Pharmaceuticals Source Type: news
12 Innovations That Will Change Health Care and Medicine in the 2020s
Pocket-size ultrasound devices that cost 50 times less than the machines in hospitals (and connect to your phone). Virtual reality that speeds healing in rehab. Artificial intelligence that’s better than medical experts at spotting lung tumors. These are just some of the innovations now transforming medicine at a remarkable pace.
No one can predict the future, but it can at least be glimpsed in the dozen inventions and concepts below. Like the people behind them, they stand at the vanguard of health care. Neither exhaustive nor exclusive, the list is, rather, representative of the recasting of public health and medic...
Source: TIME: Health - October 25, 2019 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized HealthSummit19 technology Source Type: news
Sodium –Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
In 2008, the European Medicines Agency and US Food and Drug Administration (FDA) issued industry guidance stating that all future novel glucose-lowering agent trials must undergo routine cardiovascular risk evaluation either before approval or as a post-marketing commitment.1 This mandated that all cardiovascular endpoint committees prospectively adjudicate all major adverse cardiovascular events, including cardiovascular death, non-fatal MI and stroke, occurring across Phase II and III diabetes trials.
Source: Radcliffe Cardiology - November 4, 2019 Category: Cardiology Authors: mehul Source Type: research
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
ATLANTA, Dec. 18, 2019 -- (Healthcare Sales & Marketing Network) -- NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, today announced the appointment of Todd Verdoorn, PhD., as Vice President of Research and Development. In this capacity, Dr. ... Biopharmaceuticals, Neurology, Personnel NeuroTrauma Sciences, stroke, traumatic brain injury
Source: HSMN NewsFeed - December 18, 2019 Category: Pharmaceuticals Source Type: news
What ’s the Big Deal about Data in Medtech?
Discussion, “Top 5 Things You Need to Know about the Implantable Internet of Things."
Brian Chapman, partner and leader of ZS’s medtech practice of ZS, attributes today’s focus on data to the intersection of two important things:
"A general recognition that understanding more and connecting actions with outcomes will provide feedback and understanding that will drive standards of care. This is not new, but as capabilities rise in data collection, aggregation, and synthesize rise, and coupled with machine learning, the promise of data in healthcare is becoming even more ...
Source: MDDI - December 20, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news
Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device
YOKNEAM, Israel, April 7, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the development of next generation neurovascular interventional devices, has announced that it has completed enrollment in the TIGER (Treatment... Devices, Interventional, Radiology, Neurology Rapid Medical, TIGERTRIEVER, thrombectomy, stroke
Source: HSMN NewsFeed - April 7, 2020 Category: Pharmaceuticals Source Type: news
Rapid Medical Receives CE Mark for TIGERTRIEVER(TM) XL
TIGERTRIEVER XL is the largest stentriever available, designed to safely remove clots from intracranial vessels up to 9mm in diameter
YOKNEAM, Israel, July 27, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the de... Devices, Interventional, Neurology, Regulatory Rapid Medical, TIGERTRIEVER, thrombectomy device, stroke
Source: HSMN NewsFeed - July 27, 2020 Category: Pharmaceuticals Source Type: news
Finding the everyday miracles in life
Last week I was writing about what it takes for a miracle to happen and one of my commentators, the lovely Patsy Collins who joined me on the podcast not that long ago, pointed out that there are all sorts of miracles that happen, including some everyday miracles we never know about, because they happen behind the scenes.
And it got me thinking about the all the little miracles that have happened in my life over the years. And, once I got thinking, I got into musing about what life would be like if they hadn’t happened. And, as it’s been a week of ups and downs on the exam front I thought I might as well start ...
Source: The Hysterectomy Association - August 22, 2020 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Happiness miracle Source Type: news
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation
MARLBOROUGH, Mass., Oct. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporatio... Devices, Interventional, Cardiology Boston Scientific, WATCHMAN FLX, Left Atrial Appendage, atrial fibrillation
Source: HSMN NewsFeed - October 29, 2020 Category: Pharmaceuticals Source Type: news
Rapid Medical Expands Comaneci(TM) CE Mark Indication to Include Vasospasm Treatment
Comaneci is the first adjustable mesh device indicated for the endovascular treatment of vasospasm
YOKNEAM, Israel, Nov. 23, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the development of next-generation neurov... Devices, Interventional, Neurology, Regulatory Rapid Medical, TIGERTRIEVER, thrombectomy, stroke, vasospasm
Source: HSMN NewsFeed - November 23, 2020 Category: Pharmaceuticals Source Type: news
